A research team led by the Chinese Academy of Sciences has announced the successful creation of the world’s first pigs featuring targeted edits to the Liver X Receptor alpha (LXRα) gene. This breakthrough, achieved by the Institute of Subtropical Agriculture (ISA) under the guidance of Academician Yin Yulong, involves four cloned piglets that serve as sophisticated biological models for human health research.
The LXRα gene acts as a 'master regulator' for cholesterol metabolism and inflammatory responses within the body. By precision-editing this specific receptor, scientists have effectively altered the animals' internal metabolic control system. This modification provides a unique window into how the body clears cholesterol and manages immune responses, which are critical factors in the development of chronic diseases.
While rodents have traditionally been the workhorses of genetic research, pigs offer a physiological and anatomical profile that far more closely mirrors that of humans. These new gene-edited models are specifically designed to help researchers understand the complex relationship between metabolic dysfunction and cardiovascular inflammation. Such insights are vital for developing next-generation treatments for atherosclerosis and other heart-related conditions.
This development marks a significant step in China’s broader ambition to dominate the field of biotechnology and regenerative medicine. By establishing advanced animal models that replicate human disease pathways with high fidelity, Chinese scientists are positioning themselves at the forefront of pharmaceutical testing and gene therapy. The success of the ISA team underscores the accelerating pace of CRISPR-related innovations within the country’s state-backed research institutions.